Form 4: UNITED THERAPEUTICS CEO Sells Shares
Insider Transaction (Form 4)
Martine A Rothblatt, Chairperson & CEO and a Director of UNITED THERAPEUTICS Corp, sold 9,500 shares of common stock on July 23, 2026.
Summary
- Option exercise/conversion: acquired 9,500 Common Stock at $135.42 ($1,286,490) on July 23, 2026; holds 333,943 after (Indirect).
- Open-market sale: disposed of 249 Common Stock at $522.87 ($130,195) on July 23, 2026; holds 333,694 after (Indirect).
- Open-market sale: disposed of 339 Common Stock at $523.72 ($177,540) on July 23, 2026; holds 333,355 after (Indirect).
- Open-market sale: disposed of 171 Common Stock at $524.86 ($89,751) on July 23, 2026; holds 333,184 after (Indirect).
- Open-market sale: disposed of 387 Common Stock at $525.83 ($203,497) on July 23, 2026; holds 332,797 after (Indirect).
- Open-market sale: disposed of 552 Common Stock at $526.88 ($290,835) on July 23, 2026; holds 332,245 after (Indirect).
- Open-market sale: disposed of 1,989 Common Stock at $527.77 ($1,049,730) on July 23, 2026; holds 330,256 after (Indirect).
- Open-market sale: disposed of 2,133 Common Stock at $529.08 ($1,128,525) on July 23, 2026; holds 328,123 after (Indirect).
- Open-market sale: disposed of 2,279 Common Stock at $529.86 ($1,207,540) on July 23, 2026; holds 325,844 after (Indirect).
- Open-market sale: disposed of 1,201 Common Stock at $530.84 ($637,540) on July 23, 2026; holds 324,643 after (Indirect).
- Open-market sale: disposed of 200 Common Stock at $531.83 ($106,367) on July 23, 2026; holds 324,443 after (Indirect).
- Option exercise/conversion: disposed of 9,500 Stock Option on July 23, 2026; holds 284,410 after (Indirect).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $5,021,520 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Martine A Rothblatt — Director, Officer (Chairperson & CEO)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-23 | Option exercise/conversion | Common Stock | 9,500 | $135 | $1.3M | 333,943 |
| 2026-07-23 | Open-market sale | Common Stock | 249 | $523 | $130.2K | 333,694 |
| 2026-07-23 | Open-market sale | Common Stock | 339 | $524 | $177.5K | 333,355 |
| 2026-07-23 | Open-market sale | Common Stock | 171 | $525 | $89.8K | 333,184 |
| 2026-07-23 | Open-market sale | Common Stock | 387 | $526 | $203.5K | 332,797 |
| 2026-07-23 | Open-market sale | Common Stock | 552 | $527 | $290.8K | 332,245 |
| 2026-07-23 | Open-market sale | Common Stock | 1,989 | $528 | $1.0M | 330,256 |
| 2026-07-23 | Open-market sale | Common Stock | 2,133 | $529 | $1.1M | 328,123 |
| 2026-07-23 | Open-market sale | Common Stock | 2,279 | $530 | $1.2M | 325,844 |
| 2026-07-23 | Open-market sale | Common Stock | 1,201 | $531 | $637.5K | 324,643 |
| 2026-07-23 | Open-market sale | Common Stock | 200 | $532 | $106.4K | 324,443 |
| 2026-07-23 | Option exercise/conversion | Stock Option | 9,500 | — | — | 284,410 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-23 | Option exercise/conversion (9,500 shares) |
| 2026-07-23 | Open-market sale (249 shares) |
| 2026-07-23 | Open-market sale (339 shares) |
| 2026-07-23 | Open-market sale (171 shares) |
| 2026-07-23 | Open-market sale (387 shares) |
| 2026-07-23 | Open-market sale (552 shares) |
| 2026-07-23 | Open-market sale (1,989 shares) |
| 2026-07-23 | Open-market sale (2,133 shares) |
| 2026-07-23 | Open-market sale (2,279 shares) |
| 2026-07-23 | Open-market sale (1,201 shares) |
| 2026-07-23 | Open-market sale (200 shares) |
| 2026-07-23 | Option exercise/conversion (9,500 shares) |
Keywords
insider transaction, Form 4, UTHR, UNITED THERAPEUTICS Corp, bearish, Martine A Rothblatt
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.